Ross N. England, Ph.D. - Publications

2015 Physiology Temple University, Philadelphia, PA, United States 
Physiology Biology, Pathology, Molecular Biology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Gabunia K, Herman A, Ray M, Kelemen S, England RN, Cadena RD, Foster WJ, Elliott KJ, Eguchi S, Autieri MV. Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC. Journal of Molecular and Cellular Cardiology. PMID 28257760 DOI: 10.1016/j.yjmcc.2017.02.005  1
2016 Kako F, Gabunia K, Ray M, Kelemen SE, England RN, Kako B, Scalia RG, Autieri MV. Interleukin-19 Induces Angiogenesis in the Absence of Hypoxia by Direct and Indirect Immune Mechanisms. American Journal of Physiology. Cell Physiology. ajpcell.00006.2016. PMID 27053520 DOI: 10.1152/ajpcell.00006.2016  1
2014 Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, Azuma YT, Munroy MA, Eguchi S, Autieri MV. IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation. The American Journal of Pathology. 184: 2134-43. PMID 24814101 DOI: 10.1016/j.ajpath.2014.04.001  0.88
2013 Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Orr W, Traylor JG, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV. Attenuation of experimental atherosclerosis by interleukin-19. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 2316-24. PMID 23950143 DOI: 10.1161/ATVBAHA.113.301521  0.88
2013 England RN, Preston KJ, Scalia R, Autieri MV. Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability. American Journal of Physiology. Cell Physiology. 305: C255-65. PMID 23596173 DOI: 10.1152/ajpcell.00069.2013  0.88
2012 England RN, Autieri MV. Anti-inflammatory effects of interleukin-19 in vascular disease. International Journal of Inflammation. 2012: 253583. PMID 22844641 DOI: 10.1155/2012/253583  1
2012 Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis. 220: 45-52. PMID 21862018 DOI: 10.1016/j.atherosclerosis.2011.07.095  0.88
2011 Gabunia K, Jain S, England RN, Autieri MV. Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. American Journal of Physiology. Cell Physiology. 300: C896-906. PMID 21209363 DOI: 10.1152/ajpcell.00439.2010  1
Show low-probability matches.